Department of Psychiatry, Bipolar Clinic and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Neuropsychopharmacology. 2010 Dec;35(13):2545-52. doi: 10.1038/npp.2010.122. Epub 2010 Sep 8.
Some individuals with bipolar disorder transition directly from major depressive episodes to manic, hypomanic, or mixed states during treatment, even in the absence of antidepressant treatment. Prevalence and risk factors associated with such transitions in clinical populations are not well established, and were examined in the Systematic Treatment Enhancement Program for Bipolar Disorder study, a longitudinal cohort study. Survival analysis was used to examine time to transition to mania, hypomania, or mixed state among 2166 bipolar I and II individuals in a major depressive episode. Cox regression was used to examine baseline clinical and sociodemographic features associated with hazard for such a direct transition. These features were also examined for interactive effects with antidepressant treatment. In total, 461/2166 subjects in a major depressive episode (21.3%) transitioned to a manic/hypomanic or mixed state before remission, including 289/1475 (19.6%) of those treated with antidepressants during the episode. Among the clinical features associated with greatest transition hazard were greater number of past depressive episodes, recent or lifetime rapid cycling, alcohol use disorder, previous suicide attempt, and history of switch while treated with antidepressants. Greater manic symptom severity was also associated with risk for manic transition among both antidepressant-treated and antidepressant-untreated individuals. Three features, history of suicide attempt, younger onset age, and bipolar subtype, exhibited differential effects between individuals treated with antidepressants and those who were not. These results indicate that certain clinical features may be associated with greater risk of transition from depression to manic or mixed states, but the majority of them are not specific to antidepressant-treated patients.
一些双相情感障碍患者在治疗过程中,即使没有抗抑郁治疗,也会直接从重度抑郁发作转变为躁狂、轻躁狂或混合状态。临床人群中此类转变的流行率和风险因素尚未得到很好的确立,在一项名为“双相情感障碍系统治疗增强计划”的纵向队列研究中对此进行了研究。生存分析用于检查 2166 名 I 型和 II 型双相情感障碍患者在重度抑郁发作期间向躁狂、轻躁狂或混合状态转变的时间。Cox 回归用于检查与这种直接转变风险相关的基线临床和社会人口统计学特征。还检查了这些特征与抗抑郁治疗的交互作用。在重度抑郁发作的 2166 名受试者中,共有 461 名(21.3%)在缓解前转变为躁狂/轻躁狂或混合状态,其中 1475 名接受抗抑郁治疗的患者中有 289 名(19.6%)。与最大转变风险相关的临床特征包括过去发作次数更多、近期或终身快速循环、酒精使用障碍、以前的自杀企图以及在接受抗抑郁治疗时的转换史。躁狂症状严重程度的增加也与接受和未接受抗抑郁治疗的个体的躁狂发作风险相关。自杀企图史、发病年龄较早和双相情感障碍亚型这三个特征在接受抗抑郁治疗的个体和未接受抗抑郁治疗的个体之间表现出不同的效果。这些结果表明,某些临床特征可能与从抑郁向躁狂或混合状态转变的风险增加相关,但大多数特征并非仅针对接受抗抑郁治疗的患者。